Atlas Trials

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

RecordFirmDate
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging (NCT07202494)Assistance Publique Hopitaux De Marseille2025-05-19
Cohort Study on Neuroimmune Diseases in the Reproductive Age (NCT07653984)Third Affiliated Hospital, Sun Yat-Sen University2024-04-21
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (NCT05271409)Hoffmann-La Roche2022-08-30
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD) (NCT05063162)UCB Biopharma SRL2022-02-02
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System (NCT04561557)Tongji Hospital2020-09-22
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) (NCT05017142)University of Bern2020-04-14

Track Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) automatically

Every clearance here is in the API, with alerts when new ones post.